Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
- E. Romond, E. Perez, N. Wolmark
- MedicineThe New England journal of medicine
- 20 October 2005
TLDR
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
- K. Miller, Molin Wang, N. Davidson
- Medicine, BiologyThe New England journal of medicine
- 27 December 2007
TLDR
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- A. Goldhirsch, E. Winer, W. Wood
- MedicineAnnals of oncology : official journal of the…
- 4 August 2013
The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer,…
Estrogen carcinogenesis in breast cancer.
- J. Yager, N. Davidson
- Medicine, BiologyThe New England journal of medicine
- 19 January 2006
TLDR
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:…
- M. Citron, D. Berry, L. Norton
- MedicineJournal of clinical oncology : official journal…
- 15 April 2003
TLDR
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
- S. Kaufmann, S. Desnoyers, Y. Ottaviano, N. Davidson, G. Poirier
- Biology, ChemistryCancer research
- 1 September 1993
TLDR
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
TLDR
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
TLDR
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
TLDR
...
1
2
3
4
5
...